+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Respiratory Drugs Market Research Reports

From
Cystic Fibrosis Market - Forecasts from 2024 to 2029 - Product Thumbnail Image

Cystic Fibrosis Market - Forecasts from 2024 to 2029

  • Report
  • January 2024
  • 145 Pages
  • Global
From
Budesonide Market Size, Forecast, and Drug Insight - 2032 - Product Thumbnail Image

Budesonide Market Size, Forecast, and Drug Insight - 2032

  • Report
  • February 2024
  • 30 Pages
  • Global
From
From
From
From
Alpha-1 Antitrypsin Deficiency - Epidemiology Forecast - 2032 - Product Thumbnail Image

Alpha-1 Antitrypsin Deficiency - Epidemiology Forecast - 2032

  • Report
  • January 2024
  • 106 Pages
  • Global
From
IgE receptor antagonists - Pipeline Insight, 2024 - Product Thumbnail Image

IgE receptor antagonists - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Integrin alpha4beta1 antagonists - Pipeline Insight, 2024 - Product Thumbnail Image

Integrin alpha4beta1 antagonists - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
PULMOZYME Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

PULMOZYME Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
Dupilumab Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Dupilumab Emerging Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
From
Asthma - Competitive landscape, 2023 - Product Thumbnail Image

Asthma - Competitive landscape, 2023

  • Report
  • April 2023
  • 240 Pages
  • Global
From
Loading Indicator

The Respiratory Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat respiratory diseases. These drugs are used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Commonly prescribed respiratory drugs include bronchodilators, corticosteroids, and antibiotics. The Respiratory Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in the market include GlaxoSmithKline, AstraZeneca, Merck & Co., Novartis, and Boehringer Ingelheim. These companies are constantly researching and developing new drugs to treat respiratory diseases, as well as improving existing treatments. Show Less Read more